SearcharxivSearch

arXiv subjects

Maryam Ghaffari

Publications and source records attributed to Maryam Ghaffari.

2 recordsLinked to original sources

Epitaxial Ni/Cu Superlattice Nanowires with Atomically Sharp Interfaces for Spin Transport

The importance of microstructure increases when decreasing the size of an object to the nanoscale, along with the complexity of controlling it. For instance, it is particularly complicated to create nano-object with controlled interfaces. Therefore, progressing towards 1D epitaxial nanostructures poses a challenge, and realization of their full potential is linked to technological issues of achieving large-scale, precise atom stacking of two or more different chemical elements. Achieving such coherent, epitaxial interfaces is a key step toward enabling spintronic phenomena in 1D objects, by minimizing interface scattering and strain-driven defects. Our results demonstrate a successful realization of controlled nanoscale heteroepitaxy in one-dimensional single-crystal structures. We fabricated nanowires composed of alternating magnetic (nickel) and non-magnetic, highly conductive (copper) segments. This periodic stacking modulates electron transport under magnetic stimuli. The epitaxial precision achieved eliminates detrimental electron scattering that has historically limited the magnetotransport properties of such 1D structures and hindered their development. Such materials are crucial for further advancements in the miniaturisation of nanosensors, actuators, and next-generation 3D spintronic devices.

cond-mat.mtrl-sci

Dual-trigger release of berberine chloride from the Gelatin/Perfluorohexane core-shell structure

Background: The development of smart nanocarriers that enable controlled drug release in response to internal and external triggers is an emerging approach for targeted therapy. This study focused on designing pH-sensitive, ultrasound-responsive gelatin/perfluorohexane (PFH) nanodroplets loaded with berberine chloride as a model drug. Results:The nanodroplets were prepared using an emulsion technique and optimized by varying process parameters like homogenization rate, polymer concentration, surfactant, drug, and perfluorocarbon content. The optimal formulation yielded nanodroplets with a particle size of 281.7 nm, a drug encapsulation efficiency of 66.8+- 1.7%, and a passive drug release of 15.4+- 0.2% within 24 hours. Characterization confirmed successful encapsulation and pH-responsive behavior. Ultrasound stimulation significantly enhanced drug release, with 150 kHz being more effective than 1 MHz in triggering acoustic droplet vaporization while minimizing heat generation. After 10 minutes of radiation, the optimal formulation showed 89.4% cumulative drug release. The nanodroplets displayed stability over one month at 4°C. Conclusions: Overall, the dual-triggered nanodroplets demonstrate excellent potential for controlled delivery and targeted release of berberine chloride.

q-bio.QM